Skip to content

Clinical trials

Phase 2 Presbyopia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Presbyopia Phase: Phase 2 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20164
20171
20192
20213
20225
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan4
LENZ Therapeutics, Inc4
Orasis Pharmaceuticals Ltd.3
Novartis Pharmaceuticals2
Glaukos Corporation1
Ocuphire Pharma, Inc.1
Santen Inc.1
Visus Therapeutics1
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Presbyopia18
Refractive Errors3
Eye Diseases2
Myopia2
Hyperopia1
Lens Diseases1

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.